Covis Statement on FDA Decision to Withdraw Approval of Makena®
<!-- Name:DistributionId Value:8804058 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Browsing Tag
Covis Pharma
Covis Pharma Responds to Presiding Officer’s Report Summarizing FDA Advisory…
<!-- Name:DistributionId Value:8783727 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Covis Pharma Announces Positive Topline Results from the AVANT Phase 3 Clinical Trial…
ZUG, Switzerland, Oct. 25, 2022 (GLOBE NEWSWIRE) -- Covis Pharma Group (“Covis”), a global specialty pharmaceutical company that markets therapeutic solutions for patients with…
Covis Pharma Reports on FDA Advisory Committee Hearing for Makena®
ZUG, Switzerland, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Covis Pharma Group (the “Company”), today reported that the Obstetrics, Reproductive, and Urologic Drugs Advisory Committee to the U.S.…
Covis Pharma Group Announces Executive Leadership Appointment in Canada
ZUG, Switzerland, July 14, 2022 (GLOBE NEWSWIRE) -- Covis Pharma Group (the “Company”), a global specialty pharmaceutical company that markets therapeutic solutions for patients with…
Covis Pharma Provides Update on FDA Public Hearing for Makena®
ZUG, Switzerland, June 14, 2022 (GLOBE NEWSWIRE) -- Covis Pharma GmbH, an affiliate of Group S.à r.l. (collectively, “Covis”), announced today that the U.S. Food & Drug Administration…
Covis Pharma Group annonce deux nominations au sein de son équipe de direction
- Michelle Lock rejoint Covis Pharma en tant que directrice de l'exploitation.- La Société annonce également la transition du leadership exécutif avec la nomination de Sandy Loreaux au…
Covis Pharma-Gruppe gibt zwei Ernennungen im leitenden Managementteam bekannt
- Michelle Lock kommt als Chief Operating Officer zu Covis Pharma.- Das Unternehmen gibt mit der Ernennung von Sandy Loreaux zum President, U.S. Business, außerdem einen Wechsel der…
Covis Pharma Group Announces Two Executive Management Team Appointments
- Michelle Lock Joins Covis Pharma as Chief Operating Officer.- Also Announces Executive Leadership Transition with the Appointment of Sandy Loreaux as President, U.S. Business. ZUG,…
Covis schließt Übernahme eines globalen Atemwegsportfolios mit zwei Medikamenten von…
ZUG, Schweiz, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Die Covis Pharma Group („Covis“), ein globales spezialisiertes Pharmaunternehmen, das therapeutische Lösungen für Patienten mit…